1. Diabetes raises dementia risk<\/h2>\n\n\n\n
A 2024 meta-analysis<\/a> covering more than 10 million people found that diabetes was associated with a 59% higher risk of dementia. An individual\u2019s risk still depends on age, genes, heart health, and many other factors.<\/p>\n\n\n\n Repeated hypoglycemia, the medical term for dangerously low blood sugar, was linked to a 56% higher dementia risk. Severe episodes can deprive the brain of fuel, so preventing sharp highs and lows matters.<\/p>\n\n\n\n Insulin works like a key that helps cells use glucose for energy. In type-2 diabetes<\/a>, cells stop responding properly, leaving more sugar circulating in the bloodstream.<\/p>\n\n\n\n The same problem can occur in the brain. A human brain tissue study<\/a> found weaker insulin signaling in Alzheimer\u2019s disease, and that resistance was tied to poorer memory and thinking.<\/p>\n\n\n\n The brain accounts for only about 2% of body weight, yet it uses roughly 20% of the body\u2019s energy. In dementia<\/a>, brain cells appear to become less efficient at turning glucose into usable fuel.<\/p>\n\n\n\n Think of a kitchen full of groceries but with a stove that will not light. Researchers sometimes call this pattern \u201ctype-3 diabetes\u201d, but that is an unofficial research term, not a medical diagnosis.<\/p>\n\n\n\n People with Alzheimer\u2019s disease<\/a> often show higher fasting blood sugar even without diagnosed diabetes. Animal experiments<\/a> also suggest that Alzheimer\u2019s-like changes in the brain can push glucose levels upward.<\/p>\n\n\n\n One possible player is APOE4, the strongest common genetic risk factor for late-onset Alzheimer\u2019s. Laboratory research suggests it can trap insulin receptors inside cells, but this does not prove that Alzheimer\u2019s directly causes diabetes in people.<\/p>\n\n\n\n High or unstable blood sugar can damage the tiny vessels that supply the brain with oxygen. Over time, that injury may raise the chances of stroke and vascular dementia, a condition tied to reduced blood flow in the brain.<\/p>\n\n\n\n Diabetes may also weaken the blood-brain barrier, the brain\u2019s security gate. When that barrier leaks, harmful substances can enter more easily and inflammation may follow.<\/p>\n\n\n\n Memantine was first investigated as a diabetes treatment, but it did not control blood sugar well enough. A historical review<\/a> describes how researchers later found that it could ease symptoms in some people with moderate to severe Alzheimer\u2019s disease.<\/p>\n\n\n\n The drug helps regulate glutamate, a chemical messenger that can damage brain cells when its activity becomes excessive. It does not cure Alzheimer\u2019s or stop the disease, but a failed idea found a second life.<\/p>\n\n\n\n Metformin<\/a> is one of the most widely used type-2 diabetes drugs. Researchers are studying whether its effects on inflammation and aging-related pathways could also help protect brain health.<\/p>\n\n\n\n In a study of more than 41,000 users<\/a>, people who stopped metformin early for reasons unrelated to kidney problems had a 21% higher rate of dementia diagnosis than people who continued taking it. That was an association, not proof that stopping the drug caused dementia.<\/p>\n\n\n\n GLP-1 medicines such as semaglutide<\/a> lower blood sugar and appetite, and a health-record analysis linked their use to fewer dementia diagnoses. These drugs may influence inflammation, insulin signaling, and blood vessel health.<\/p>\n\n\n\n The large Evoke and Evoke Plus trials<\/a> delivered a reality check, though. Among 3,808 adults with early Alzheimer\u2019s disease, oral semaglutide did not slow the loss of memory and daily function compared with an inactive placebo.<\/p>\n\n\n\n Prevention may still be a different question. On July 13, 2026, Maria C. Carrillo of the Alzheimer\u2019s Association said a new trial<\/a> aims to \u201cbetter understand how to meaningfully reduce the risk of cognitive decline before symptoms begin.\u201d<\/p>\n\n\n\n Researchers have tested insulin delivered through the nose, a route intended to carry the hormone toward the brain while limiting its effects on blood sugar elsewhere. Small trials have reported possible benefits for memory or reduced brain shrinkage.<\/p>\n\n\n\n The method is not ready for routine care. Different devices deliver different amounts, and scientists still need clearer evidence about long-term safety and who might benefit.<\/p>\n\n\n\n SGLT2 inhibitors lower blood sugar by helping the kidneys remove glucose through urine. Observational studies have linked them to lower rates of Alzheimer\u2019s disease and vascular dementia compared with several other diabetes treatments.<\/p>\n\n\n\n Are they better for the brain than GLP-1 drugs? One 2025 study<\/a> favored SGLT2 inhibitors, while the separate JAMA Neurology analysis<\/a> found no meaningful difference between the two classes. No one should switch diabetes medication for dementia prevention without speaking with a clinician.<\/p>\n\n\n\n The original expert analysis was published by <\/a>The Conversation<\/a>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Blood sugar may seem far removed from memory. Yet a growing body of research suggests diabetes and dementia are connected … <\/p>\nRead More: New findings suggest diabetes and dementia are linked more closely than you think, and it could change how you protect your brain<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
2. Insulin resistance reaches the brain<\/h2>\n\n\n\n
3. Dementia creates an energy squeeze<\/h2>\n\n\n\n
![\"Insulin](\"https:\/\/okdiario.com\/metabolic\/en\/wp-content\/uploads\/2026\/08\/diabetes-insulin-brain-health-dementia-risk.jpg\" "\\"\\"")
Diabetes testing and treatment tools are shown alongside a diagnosis form as researchers investigate the growing connection between blood sugar control and dementia risk.<\/figcaption><\/figure>\n\n\n\n4. The link may run both ways<\/h2>\n\n\n\n
5. Blood vessels connect the diseases<\/h2>\n\n\n\n
Read More: Walking protects more than your heart: experts say hitting a certain “golden step” count each day could slow how fast your brain ages<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
6. A diabetes failure became a dementia drug<\/h2>\n\n\n\n
7. Metformin offers a clue<\/h2>\n\n\n\n
8. GLP-1 drugs bring mixed news<\/h2>\n\n\n\n
9. Insulin sprays target the brain<\/h2>\n\n\n\n
Read More: Scientists may have found a way to switch off the trick cancer cells use to survive treatment and spread<\/a><\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
10. SGLT2 drugs may protect memory<\/h2>\n\n\n\n